Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses

• Главные авторы: S. V. Akinshina (Автор), V. O. Bitsadze (Автор), J. Kh. Khizroeva (Автор), K. N. Grigorieva (Автор), E. V. Slukhanchuk (Автор), M. V. Tretyakova (Автор), V. I. Tsibizova (Автор), I. Elalamy (Автор), J.-C. Gris (Автор), B. Brenner (Автор), E. Grandone (Автор), C. Ay (Автор), A. D. Makatsariya (Автор)
• Формат: ‌
• Опубликовано: IRBIS LLC, 2021-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

After the vaccination campaign initiation in Europe and the UK, reports of rare cases of atypical thrombosis, including sinus vein thrombosis and splanchnic venous thrombosis, began to appear in association with the use of vector vaccines AstraZeneca (ChAdOx1) and Johnson & Johnson/Janssen. The...